Professional Experience
2015 – now: Professor of genitourinary radiotherapy
2002: Training in sexual medicine
2001: PhD in radiotherapy-urology-sexology
1996-2000: Training in radiation oncology
Expertise and Research Interests
- Radiation therapy for genito-urinary cancer
- Sexual dysfunction after treatment of cancer
Selected Publications
- Incrocci L, Wortel RC, Ghidey AW, Aluwini S, Schimmel E, Krol S, van der Toorn PP, de Jager H, Heemsbergen W, Heijmen B, Pos F. Hypofractionated versus conventionally fractionated radiotherapy for localized prostate cancer; five-year relapse-free survival from the randomised phase III HYPRO trial. Lancet Oncol 2016;17:1061-9.
- Incrocci L. Is there a sexual life after treatment of cancer? Transl Androl Urol 2015;4:92-94.
- Mulhall JP, Hall M, Broderick GA, Incrocci L. Radiation therapy in Peyronie’s disease. J Sex Med 2012;9:1435-1441.
- Incrocci L, Slagter C, Slob AK, Hop WCJ. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis®) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006;66:439-44.
COST Action
European Sexual Medicine Network
COST Action CA18124
COST
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Contact
COST Association
Avenue du Boulevard – Bolwerklaan 21
1210 Brussels, Belgium
Tel: +32 (0)2 533 3800
Fax: +32 (0)2 533 3890